# Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness

> **NCT01460121** · NA · COMPLETED · sponsor: **Meir Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Chronic Dizziness

## Interventions

- **DEVICE:** SpotOn's corrective elements for dizziness
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01460121
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460121, "Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01460121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*